Nexterone Injection, Solution
Product Images NDC 43066-360

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nexterone (NDC 43066-360). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amiodarone HCl Structural Formula (Image 01)

Chemical structure diagram of amiodarone hydrochloride, the active ingredient in Nexterone injection solution. The structure shows a complex molecular arrangement including iodine atoms and a hydrochloride group, consistent with the chemical composition of amiodarone hydrochloride.*

FDA Label Image

Representative Container Label 43066-360-20 (Image 02)

Nexterone (amiodarone HCl) premixed injection label for intravenous use, strength 1.8 mg/mL in a 200 mL single-dose container delivering 360 mg total. The label shows product details including its iso-osmotic solution in dextrose, sterility, and nonpyrogenic status. It is manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA.*

FDA Label Image

Representative Carton Label 43066-360-20 (Image 03)

Nexterone (amiodarone hydrochloride) Premixed Injection label for intravenous use contains 360 mg per 200 mL (1.8 mg/mL) solution. The packaging indicates it is a prescription drug supplied by Baxter Healthcare Corporation. The label includes storage, dosage, and handling instructions, emphasizing protection from light until use and single-dose container disposal.*

FDA Label Image

Nexterone Representative Shipper Label 43066-360-20 (Image 04)

Nexterone (amiodarone HCl) Premixed Injection label for intravenous use, 150 mg per 100 mL (1.5 mg/mL) strength in a 100 mL single-dose container. The label states the product is an iso-osmotic solution in dextrose, sterile, and nonpyrogenic. It is manufactured by Baxter Healthcare Corporation.*

FDA Label Image

Representative Container Label 43066-150-10 (Image 05)

Packaging label for Nexterone (amiodarone hydrochloride) Premixed Injection 150 mg/100 mL (1.5 mg/mL) intravenous injection. The label indicates it is a single-dose container with storage, dosage, and handling instructions. The labeler is Baxter Healthcare Corporation, with emphasis on protecting contents from light until use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.